Michael Vincent Meluzio sold $169K of Cue Biopharma, Inc. (CUE) stock

Michael Vincent Meluzio, VP, Prin. Accounting Officer of Cue Biopharma, Inc. (CUE), sold 5,628 shares of CUE stock worth $169K, per an SEC Form 4 filed Aug 17, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 13, 2026, 4 days before it was made public.

CUE has moved -0.6% since the trade date, from $31.08 to $30.90 (Sep 22, 2026 close).